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Background
On-site monitoring is a high-cost process, particularly if
used indiscriminately in a large multicentre clinical trial.
Ideally, the focus should be on identification and resolu-
tion of serious problems in trial conduct affecting patient
safety and/or data quality. Targeted monitoring, where
trial data and conduct are scrutinised centrally, with pre-
specified triggers for site visits, may be an efficient way to
prioritise on-site monitoring. Though widely used, this
approach has not been formally evaluated.
Methods
With funding from CRUK, and using a prospective
matched-pair design, we are evaluating targeted monitor-
ing within several multicentre cancer trials being
conducted by the MRC Clinical Trials Unit. Using the
pre-specified triggers for each trial, sites prioritised for a
site visit will be matched (on number of patients
recruited and time since trial site opened) with one that
would not be visited based on the normal monitoring
strategy. Paired sites will be visited and a standard moni-
toring report completed. The primary analysis will com-
pare the proportion of sites with at least one critical or
major monitoring finding in triggered vs. matched sites.
84 visits (42 pairs) will be carried out; the study is pow-
ered to detect a 30% difference in the proportion of sites
with critical/ major findings (80% power, 5% 2 sided-sig-
nificance level). An important secondary analysis will
evaluate individual triggers as prognostic factors for
findings.
Status
The study is on-going; progress including development
of reports to help monitor triggers, and the practical
challenges in embedding evaluative methodological stu-
dies in open trials will be presented.
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